What is it about?
In this paper, we assessed how patients' vascular complications after a transcatheter aortic valve replacement (TAVR) affect their health outcomes. To do so we used data from the Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapy Registry (STS/ACC TVTR)---from 2011-2015 with about 15,700 patients from 359 US hospitals---to determine temporal trends in vascular complications and in-hospital bleeding and their relationship with in-hospital mortality. We demonstrate that although the rate of vascular complications and bleeding have decreased over time, both vascular complications and bleeding are still associated with short- and long-term adverse events such as mortality.
Featured Image
Why is it important?
This is important since little is known so far about the rates of vascular complications and bleeding and their relationship with long-term TVAR related outcomes.
Perspectives
Following the approval of the new transcatheter valve therapy (TVT) for the treatment of aortic valve stenosis, STS and ACC launched the STS/ACC TVT Registry in December of 2012 to track the real-world outcomes related to TVT procedures. As an alternative to the conventional valve replacement surgery for patients deemed non-operable, the option of using TVT procedures for transcatheter aortic valve replacement needed a national evaluation program to evaluate their safety and efficacy. This study follows that ambitious goal to provide meaningful assessment how effective and appropriate TAVR is and evaluate the quality of care being carried out.
Dr. Roland A. Matsouaka
Duke University
Read the Original
This page is a summary of: TCT-78 Incidence and Outcomes of Vascular Complications and Bleeding Events in Patients undergoing TAVR in contemporary U.S. practice: Insights from the STS/ACC TVT Registry®, Journal of the American College of Cardiology, November 2016, Elsevier,
DOI: 10.1016/j.jacc.2016.09.226.
You can read the full text:
Contributors
The following have contributed to this page
